The Effects of Selective Serotonin-Reuptake Inhibitor on Visual Evoked Potential in Rats

4Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.

Abstract

The present study was undertaken to clarify the effects of selective serotonin-reuptake inhibitors (SSRIs) on visual evoked potential (VEP) in rats. To elucidate the mechanism of action of SSRIs, some serotonin (5-HT) agonists were used. SSRIs, fluvoxamine and paroxetine, caused a reduction in the amplitudes of P1-N1, P3-N3, and N3-P4 components of VEP. The amplitude of the P 1-N1 component was also reduced by the 5-HT1A agonist 8-OH-DPAT and 5-HT1B agonist anpirtoline. On the other hand, amplitudes of P3-N3 and N3-P4 components were reduced by anpirtoline and the 5-HT2 agonist DOI. These results indicate that the reduction in the amplitude of the P 1-N1 component of VEP induced by SSRIs may participate in 5-HT1A and 5-HT1B receptors, and those of P 3-N3 and N3-P4 components induced by SSRIs may be closely related with 5-HT1B and 5-HT2 receptors.

Cite

CITATION STYLE

APA

Iwamura, Y., Fujii, Y., & Kamei, C. (2004). The Effects of Selective Serotonin-Reuptake Inhibitor on Visual Evoked Potential in Rats. Journal of Pharmacological Sciences, 94(3), 271–276. https://doi.org/10.1254/jphs.94.271

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free